Postdiagnosis circulating osteoprotegerin and trail concentrations and survival and recurrence after a breast cancer diagnosis: results from the marie patient cohort

HIGHLIGHTS

• who: Charlotte Le Cornet from the participating clinics and cancer registriesTo be eligible, patients had to reside in one of the study regions and be capable of participating in a, ., h in-person interview. Patients were identified through frequent monitoring of hospital admissions, surgery schedules, and pathology records of all clinics serving these regions and also through the Hamburg Cancer Registry. In, patients were re-interviewed about weight and other exposures and a subset provided a second blood sample, and follow-up information about endpoints was ascertained in , and, . The study was approved by the ethics committees . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.